glp-1 therapy for diabetes GLP‐1 Receptor Agonist and Cardiorenal Outcomes in Patients ≥ 80 Years Old With Type 2 - Chen - 2026 - Journal of the American Geriatrics Society Long-term Success of GLP-1s Hinges

GLP-1 is a hormone released in the gut after meals

Tariq says

Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors, has shown even more dramatic weight loss in clinical trials, with some participants losing over 25% of their body weight

How does this change GLP-1 Drug Marketing

GLP-1 increased the expression of mRNA and transcription factors that play a part in the pleiotropic effects such as DNA synthesis in pancreatic beta cells, metabolic enzyme gene expression, and insulin biosynthesis

Detailed Information: PureRawz provides detailed research summaries for each peptide on its website, including liraglutide